洛诺西卡姆的抗血栓潜力和可能的机制性途径
Waseem Khalid1, Arif-Ullah Khan1, Fawad Ali2
1Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
The Journal of pharmacology and experimental therapeutics
|September 18, 2025
概括
洛诺西卡姆显示出显著的抗血栓和心脏保护作用,降低心肌梗塞和肺栓塞的风险. 这种非类固醇抗炎药物显示出在高风险患者中预防性使用的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
- 血栓形成研究研究
背景情况:
- 洛诺西卡姆是一种非类固醇抗炎药物 (NSAID),以其抗炎和止痛特性而闻名.
- 新出现的证据表明,NSAIDs可能会影响血小板和凝血通路.
- 洛诺西卡姆的抗血栓和心肺保护潜力在很大程度上仍未得到研究.
研究的目的:
- 评估洛诺西卡姆的抗血栓和心肺保护作用.
- 探索洛诺西卡姆在预防心肌梗塞 (MI) 和肺栓塞 (PE) 的潜力.
- 调查洛诺西卡姆除了循环氧化酶 (COX) 抑制之外的机制.
主要方法:
- 在16个蛋白对抗16个蛋白的分子对接和动态模拟中.
- 在体外测定血小板聚合 (诱导的阿拉基酸和ADP).
- 在体内研究使用老鼠模型进行心肌梗塞和肺栓塞,并进行生物化学和组织学分析.
主要成果:
- 洛诺西卡姆对包括COX-1,糖蛋白IIb/IIIa和NFκB在内的关键蛋白质表现出高的结合亲和力.
- 观察到度依赖于血小板聚合的抑制,具有显著的抗血栓作用.
- 洛诺西卡姆在体内表现出显著的心脏保护和肺部保护作用,通过调节炎症标志物来减少组织损伤和炎症.
结论:
- 洛诺西卡姆具有显著的抗血栓和心肺保护性质.
- 药物的作用超出了COX抑制的范围,涉及像NFκB这样的途径.
- 洛诺西卡姆为患有血栓性疾病风险的患者提供了潜在的预防方案,类似于阿司匹林.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
01:30Combined Effects of Drugs: Antagonism
11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
01:31Transducer Mechanism: Nuclear Receptors
2.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.4K